Search Results 1041-1050 of 17991 for Alcoholics

  1. Integrative medicine - Doctors & Departments - Mayo Clinic

    Integrative medicine combines complementary and alternative medicine (CAM) practices with conventional medicine.

  2. Health Behaviors Among Hispanic and Somali Adults at Risk for Cardiovascular Disease - Mayo Clinic

    The purpose of this study is to conduct a social network analysis to identify peer interventionists and to assess existing social structures that contribute to ...

  3. Narcolepsy - Doctors and departments - Mayo Clinic

    Learn more about this sleep condition that causes periods of involuntary sleep, sleep paralysis and early rapid eye movement (REM) sleep.

  4. Mental illness - Symptoms and causes - Mayo Clinic

    A wide range of mental health conditions affect mood, thinking and behavior and can make you miserable and cause problems in daily life.

  5. Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The Investigational Device Uses Iron Oxide Nanoparticles Together With Non-Ionizing Alternating Magnetic Field To Generate Heat And Destroy Tumors - Mayo Clinic

    Early Feasibility Study To Evaluate The Safety And Recommended Dose Of The Sarah Nanotechnology System, For Patients With Stage 4 Metastatic Solid Tumors.The ...

  6. Cholecystectomy (gallbladder removal) - Doctors & Departments - Mayo Clinic

    ... Alcoholic liver disease, Portal hypertension, Chronic liver disease, Budd-Chiari syndrome, Metabolic liver disease, Polycystic liver disease. Show more areas ...

  7. Opioid Use After PCNL - Clinical Trials

    About this study. The purpose of the study is to assess patients' use of opioid and non-opioid pain medication following percutaneous nephrolithotomy, ...

  8. The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy - Mayo Clinic

    The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy. Participation ...

  9. A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Subjects With Select Advanced Malignancies - Mayo Clinic

    A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in ...

  10. A Study of MCLA-128 in Patients with Solid Tumors Harboring an NRG1 Fusion - Mayo Clinic

    About this study. The purpose of this study is to assess the safety, tolerability, movement (pharmcokinetics, "PK"), biological response (pharmacodynamics, ...